Literature DB >> 16895876

Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging.

Susan L Colles1, John B Dixon, Paul Marks, Boyd J Strauss, Paul E O'Brien.   

Abstract

BACKGROUND: A very-low-energy diet (VLED) can result in substantial, rapid weight loss and is increasingly prescribed before obesity surgery to minimize risk and difficulty by reducing liver size and abdominal adiposity. Despite its growing popularity, a VLED in this setting has received little attention.
OBJECTIVE: The aim of this study was to investigate the efficacy and acceptability of a preoperative VLED.
DESIGN: In a prospective observational study, 32 subjects (n = 19 men and 13 women) with a mean (+/-SD) age of 47.5 +/- 8.3 y and a body mass index (in kg/m(2)) of 47.3 +/- 5.3 consumed a VLED for 12 wk. Primary outcomes included changes in liver volume (LV) and in visceral and subcutaneous adipose tissue (VAT/SAT). Changes in body weight, anthropometric measures, and biochemical variables were also recorded, and compliance with, acceptability of, and side effects of treatment were assessed. Changes in LV and VAT/SAT area were measured by computed tomography and magnetic resonance imaging at baseline and weeks 2, 4, 8, and 12.
RESULTS: Mean (+/-SD) LV, VAT/SAT, and body weight decreased significantly (P < 0.001 for all). The degree of LV reduction was directly related to the reduction in relative body weight (r = 0.54, P = 0.001) and initial LV (r = 0.43, P = 0.015). Eighty percent of the reduction in LV occurred between weeks 0 and 2 (P < 0.001). Reductions in body weight and VAT were uniform over the 12-wk period. Attrition was 14%. Acceptability was adequate but waned over time, and mild transitory side effects occurred.
CONCLUSIONS: Given the observed early reduction in LV and the progressive reduction in VAT, we suggest that the minimum duration for a preoperative VLED be 2 wk. Ideally, the duration should be 6 wk to achieve maximal LV reduction and significant reductions in VAT and body weight without compromising compliance and acceptability.

Entities:  

Mesh:

Year:  2006        PMID: 16895876     DOI: 10.1093/ajcn/84.1.304

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  96 in total

1.  Predictors of short-term diabetes remission after laparoscopic Roux-en-Y gastric bypass.

Authors:  Gianluca Iacobellis; Chengyu Xu; Rafael E Campo; Nestor F De La Cruz-Munoz
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese.

Authors:  David Edholm; Joel Kullberg; Arvo Haenni; F Anders Karlsson; Anders Ahlström; Jakob Hedberg; Håkan Ahlström; Magnus Sundbom
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

3.  Laparoscopic adjustable banded roux-en-y gastric bypass as a primary procedure for the super-super-obese (body mass index > 60 kg/m²).

Authors:  Bruno Dillemans; Sebastiaan Van Cauwenberge; Sanjay Agrawal; Els Van Dessel; Jan-Paul Mulier
Journal:  BMC Surg       Date:  2010-11-14       Impact factor: 2.102

4.  Weight loss prior to bariatric surgery is not a pre-requisite of excess weight loss outcomes in obese patients.

Authors:  Guillaume Becouarn; Philippe Topart; Patrick Ritz
Journal:  Obes Surg       Date:  2010-02-20       Impact factor: 4.129

5.  Pre-operative dietary restriction for patients undergoing bariatric surgery in the UK: observational study of current practice and dietary effects.

Authors:  Emma L Baldry; Paul C Leeder; Iskandar R Idris
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

6.  Linear Mixed Effects Analysis Reveals the Significant Impact of Preoperative Diet Success on Postoperative Weight Loss in Gastric Bypass Surgery.

Authors:  Rebecca Kraus; Daniel J Stekhoven; Ulrich Leupold; Walter R Marti
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

7.  Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study.

Authors:  B Coffin; V Maunoury; F Pattou; X Hébuterne; S Schneider; M Coupaye; S Ledoux; F Iglicki; F Mion; M Robert; E Disse; J Escourrou; G Tuyeras; Y Le Roux; C Arvieux; P Pouderoux; N Huten; T Alfaiate; D Hajage; S Msika
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

8.  Outpatient laparoscopic adjustable gastric banding in super-obese patients.

Authors:  Kevin F Montgomery; Brad M Watkins; Jessie H Ahroni; Robert Michaelson; Ronald E Abrams; Marc D Erlitz; James E Scurlock
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

Review 9.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

10.  Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Arul Earnest; Paul E O'Brien; Wendy A Brown
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.